7:00 a.m. – 8:00 a.m. Palm BC

Sign-in

8:00 a.m. – 10:00 a.m.

Reports from Round Table Discussions

Four 30-minute talks

#1 Imaging, Biomarkers & Radiomics

• 01: Eric Grogan, MD, Vanderbilt -Ingram Cancer Center
• Matthew Schabath, PhD, H. Lee Moffitt Cancer Center & Research Institute, Inc.
• Guillermo Marquez, PhD, National Cancer Institute

#2 Digital Pathology – AI and ML

• 02: Anirban Maitra, MBBS, The University of Texas MD Anderson Cancer Center
• Andrew Hoofnagle, MD, PhD, University of Washington
• Sidney Fu, MD, National Cancer Institute

#3 Spatial-Omics

• 03: Cecilia Yeung, MD, Fred Hutchinson Cancer Center
• O. John Semmes, PhD, Eastern Virginia Medical School
• Indu Kohaar PhD, National Cancer Institute

#4 Cell Free DNA

• 04: Cristian Tomasetti, PhD, City of Hope/Tgen
• Joshua LaBaer, MD, PhD, Arizona State University
• Christos Patriotis PhD, National Cancer Institute

10:00 a.m. – 10:20 a.m.

Break

10:20 a.m. – 11:20 a.m.

Updates on EDRN Core Funded Projects

National Liver Cancer Screening Trial (TRACER) - Clinical Utility Trial for Hepatocellular Carcinoma

• 05: Amit Singal, MD, University of Texas Southwestern

Prostate MRI Biomarker Study (PMRI)

• 06: John T. Wei, MD, University of Michigan (virtual)

Pancreas CT Study

• 07: Anirban Maitra, MBBS, The University of Texas MD Anderson Cancer Center

11:20 a.m. – 11:30 a.m.

Final Remarks

• Karen Anderson, MD, PhD, Arizona State University
• Arul Chinnaiyan MD, University of Michigan

11:30 a.m.

Adjourn